People · Operator
Named in public records as an officer, director or promoter · active 2014–2026 · Other Technology, Healthtech, AI / ML, Fintech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bowery Farming Inc. | — | Other Technology | Series D+ | $527.8M | $1.2B | 2017 |
| K Health, Inc. | — | Healthtech | Series D+ | $353.4M | $915.7M | 2021 |
| GrubMarket, Inc. | — | AI / ML | Series D+ | $279.1M | $7.5B | 2015 |
| Frubana Inc | — | Fintech | Series D+ | $275.0M | $358.6M | 2021 |
| Misfit Wearables Corp | — | Other Technology | Series B | $63.0M | $1.2B | 2014 |
| Curse, Inc. | — | Other | Series B | $52.4M | $498.4M | 2014 |
| FlightCar Inc. | — | Other | Series B | $40.6M | $344.2M | 2014 |
| ViaVia Corp | — | Other Technology | Series B | $32.4M | $92.4M | 2025 |
| DASTA Inc | — | Other Technology | Series B | $26.3M | $152.6M | 2025 |
| Yami Investment Ltd | — | Other Technology | Series A | $22.6M | $240.4M | 2019 |
| Transocean Resources Management, Inc. | — | Other | Series A | $10.0M | $151.3M | 2017 |
Hans Tung at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hans Tung on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| You Zhou | 2 | 2 |
| Antonio Gracias | 1 | 15 |
| David Golden | 1 | 11 |
| Jean-Francois Clavier | 1 | 10 |
| ROB HAYES | 1 | 9 |
| Greg Johnson | 1 | 9 |
| Brian Singerman | 1 | 9 |
| Sonny Vu | 1 | 7 |
| Carlo Dapuzzo | 1 | 7 |
| Jason Wong | 1 | 6 |
| Andy Wheeler | 1 | 6 |
| Michael Lynton | 1 | 6 |
| John Sculley | 1 | 6 |
| Xuezhao Lan | 1 | 5 |
| Alejandro Zubillaga | 1 | 5 |
| Jordan Nof | 1 | 4 |
| Allon Bloch | 1 | 4 |
| JIE CHEN | 1 | 4 |
| Michael Acheson | 1 | 3 |
| MARK TLUSZCZ | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.